Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_assertion type Assertion NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_head.
- NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_assertion description "[In neonates, CpG pretreatment led to a transient increase in expression of major histocompatibility complex class II (MHCII) and CD80 on CD11c-positive cells and gamma interferon (IFN-?) production by NK cells after RSV infection, suggesting that the protective effects may be mediated by antigen-presenting cells (APC) and NK cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_provenance.
- NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_assertion evidence source_evidence_literature NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_provenance.
- NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_assertion SIO_000772 22811525 NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_provenance.
- NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_assertion wasDerivedFrom befree-20140225 NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_provenance.
- NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_assertion wasGeneratedBy ECO_0000203 NP715222.RAlEgFs4X6ZhkH1WPz4w9QlCbEHYEOEkMpFa_o41wp_K4130_provenance.